Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma

Surgical Resection or Ablation for Recurrent Pancreatic Ductal Adenocarcinoma

Objective:. To evaluate the survival benefits of curative-intent treatment (CIT, including surgery or ablation) for recurrent pancreatic ductal adenocarcinoma (PDAC) depending on the recurrence type and compared the survival outcomes with other treatment modalities. Background:. The treatment for re...

Full description

Bibliographic Details
Main Authors:	Boram Lee, MD, Ho-Seong Han, MD, PhD, Jun Suh Lee, MD, PhD, Yoo-Seok Yoon, MD, PhD
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2021-09-01
Series:	Annals of Surgery Open
Online Access:	http://journals.lww.com/10.1097/AS9.0000000000000096

Similar Items

Predictors of occult metastases in potentially Resectable pancreatic ductal adenocarcinoma
by: Takeshi Murakami, MD, et al.
Published: (2024-08-01)

Long-Term Outcomes of Venous Resections in Pancreatic Ductal Adenocarcinoma Patients
by: Martin Sillesen, MD, PhD, et al.
Published: (2022-12-01)

Surgical Outcomes Following Neoadjuvant Treatment for Locally Advanced and Borderline Resectable Pancreatic Ductal Adenocarcinoma
by: Kai Tai Derek Yeung, PhD, FRCS, et al.
Published: (2024-09-01)

Current Treatment of Potentially Resectable Pancreatic Ductal Adenocarcinoma: A Medical Oncologist’s Perspective
by: Victor Hugo Fonseca de Jesus MD, MSc, et al.
Published: (2023-04-01)

Pancreatic ductal adenocarcinoma: the role of circulating tumor DNA
by: Joseph R. Habib, MD, et al.
Published: (2019-09-01)

Preoperative Biliary Drainage Does Not Independently Reduce Survival After Pancreaticoduodenectomy Among Patients With Pancreatic Ductal Adenocarcinoma
by: Karin Johansen, MD, et al.
Published: (2021-09-01)

Clinical Features and Computed Tomography Radiomics-Based Model for Predicting Pancreatic Ductal Adenocarcinoma and Focal Mass-Forming Pancreatitis
by: Yingjian Ye MD, et al.
Published: (2023-06-01)

Review and Application of Integrin Alpha v Beta 6 in the Diagnosis and Treatment of Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
by: Yunyu Lian BM, et al.
Published: (2023-08-01)

Impact of Preoperative Malnutrition on Postoperative Long-Term Outcomes of Patients With Pancreatic Head Cancer
by: Boram Lee, MD, et al.
Published: (2021-03-01)

Comment on “Perineural Invasion In Pancreatic Ductal Adenocarcinoma—What Can We Learn From The Past?’’
by: Xiaofei Shen, MD, PhD
Published: (2021-06-01)

Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Bioinformatics and Next-Generation Sequencing Data Analysis
by: Muttanagouda Giriyappagoudar MD, et al.
Published: (2023-07-01)

Comment on: “Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma”
by: Yangyang Zheng, MM, et al.
Published: (2023-03-01)

Serum High-Density Lipoprotein Cholesterol Concentrations in Pancreatic Ductal Adenocarcinoma and Its Association With Histological Grade in a Chinese Population
by: Ying-Ying Cao PhD, et al.
Published: (2025-01-01)

A case of recurrent laryngeal nerve paralysis caused by radiofrequency ablation for mediastinal recurrence of lung cancer
by: Kazuki Murai, MD, PhD, et al.
Published: (2024-04-01)

Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinomaCentral MessagePerspective
by: Yasuyuki Kurihara, MD, et al.
Published: (2024-08-01)

The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma
by: Hiroaki Kanemura, MD, MPH, PhD, et al.
Published: (2024-04-01)

Compute Tomography Radiomics Analysis on Whole Pancreas Between Healthy Individual and Pancreatic Ductal Adenocarcinoma Patients: Uncertainty Analysis and Predictive Modeling
by: Shuo Wang PhD, et al.
Published: (2022-10-01)

Patient Perceptions of Decision-making and Quality-of-life Following Surgical Resection of Pancreatic Adenocarcinoma
by: Josh Bleicher, MD, MS, et al.
Published: (2022-12-01)

Response to: “Comment on: Prognostic Effect of Liver Resection in Extended Cholecystectomy for T2 Gallbladder Cancer Revisited: A Retrospective Cohort Study with Propensity-Score-Matched Analysis”
by: Yeshong Park, MD, et al.
Published: (2023-12-01)

Added Value of Liver MRI in Patients Eligible for Surgical Resection or Ablation of Colorectal Liver Metastases Based on CT: A Systematic Review and Meta-Analysis
by: Burak Görgec, MD, et al.
Published: (2024-03-01)

Preoperative Decision to Perform Portal Vein Resection Improves Survival in Patients With Resectable Pancreatic Head Cancer Adjacent to Portal Vein
by: Muga Terasawa, MD, et al.
Published: (2021-06-01)

Effect of miR-184 on Proliferation and Apoptosis of Pancreatic Ductal Adenocarcinoma and Its Mechanism
by: Shentao Li MBBS, et al.
Published: (2020-09-01)

Endoscopic treatment of large impacted pancreatic ductal stone using digital pancreatoscopy and electrohydraulic lithotripsy
by: Hitoshi Shibuya, MD, et al.
Published: (2018-03-01)

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
by: Yejong Park, et al.
Published: (2021-01-01)

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection.
by: Toshitaka Sugawara, et al.
Published: (2021-01-01)

Comment on “Surgical Margin of Resected Colorectal Liver Metastases: How Accurate Is Surgeon Prediction?”
by: Yoichiro Uchida, MD, PhD, et al.
Published: (2024-09-01)

Moisturization of the Surgical Field during Cancer Resection Reduces Perioperative Complications in Reconstruction Surgery
by: Megumi Ishii, MD, et al.
Published: (2022-05-01)

EUS-guided radiofrequency ablation for a left adrenal oligometastasis of an esophageal adenocarcinoma
by: Akin Inderson, MD, et al.
Published: (2018-05-01)

Surgical Resection of Cardiac Paragangliomas Surrounding Both Coronary ArteriesNovel Teaching Points
by: Rohit K. Kharbanda, MD, PhD, et al.
Published: (2024-01-01)

Clinical Relevance of Patient-Derived Organoid of Surgically Resected Lung Cancer as an In Vitro Model for Biomarker and Drug Testing
by: Takamasa Koga, MD, PhD, et al.
Published: (2023-09-01)

Impact of Endoscopic Surgical Skill Qualification on Laparoscopic Resections for Rectal Cancer in Japan: The EnSSURE Study
by: Nobuki Ichikawa, MD, PhD, et al.
Published: (2022-06-01)

Brief Report: circRUNX1 as Potential Biomarker for Cancer Recurrence in EGFR Mutation-Positive Surgically Resected NSCLC
by: Carlos Pedraz-Valdunciel, PhD, et al.
Published: (2023-12-01)

Isolated colonic metastasis two years after resection of stage IA primary adenocarcinoma of the lung: A case report
by: Stylianos Vittorakis, MD, PhD, et al.
Published: (2018-01-01)

Scorecards: Quantifying Dosimetric Plan Quality in Pancreatic Ductal Adenocarcinoma Stereotactic Body Radiation Therapy
by: Kareem Rayn, MD, et al.
Published: (2023-11-01)

Salvage endoscopic resection for perforation site recurrence of colonic polyp
by: Deepak Madhu, MD, MRCP, DM, et al.
Published: (2024-07-01)

Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
by: Ana Acuna-Villaorduna MD, et al.
Published: (2022-10-01)

Response to: Comment on “Dynamics of Serum CA 19-9 in Patients Undergoing Pancreatic Cancer Resection”
by: Vincent P. Groot, MD, PhD, et al.
Published: (2024-06-01)

Clinical Course and Predictors of Subsequent Recurrence and Survival of Patients With Ipsilateral Breast Tumor Recurrence
by: Soo Yeon Baek MD, et al.
Published: (2022-03-01)

Duodenal duplication cyst: a rare cause of recurrent pancreatitis
by: Guillaume Perrod, MD, et al.
Published: (2018-02-01)

Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
by: Chen Liu MD, PhD, et al.
Published: (2020-04-01)